Expert Pitch
Florida State University

FSU expert available to comment on effectiveness of flu vaccine

17-Feb-2020 9:00 AM EST, by Florida State University

By: Bill Wellock | Published: | 3:35 pm | SHARE: Share on FacebookTweet

Newswise — As an outbreak of a new coronavirus makes headlines across the world, another more common infectious disease is spreading across the United States and beyond — the flu.

About 8 percent of the U.S. population gets sick from the flu each season, according to the Centers for Disease Control and Prevention. Although anyone can get sick, people 65 years and older, children younger than 5, pregnant women and people with medical conditions are at greater risk of serious complications.

Dr. Christie Alexander, an associate professor at the Florida State University College of Medicine and president of the Florida Academy of Family Physicians, is available to explain how scientists develop each year’s flu vaccine, why its effectiveness varies and whether it’s still worth getting a flu shot in February.

How does the development process for each year’s flu vaccine work?
Development starts right around the end of the previous year’s flu season, and it’s based on that year’s flu season. Scientists try to develop the vaccine based on that season, looking back to see what the rates of the various flu strains were and then developing the flu vaccine according to that, trying to anticipate what the next flu season will look like.

Can you talk about the different strains?
There’s influenza A and influenza B. The flu shot is trying to prevent against two strains of A and two strains of B. Those strains mutate every year, so scientists try to target the mutations as best they can and create the vaccine based on what those strains looked like that year.

Why is the vaccine sometimes more or less effective?
This is because the strains mutate so quickly and so readily. Even after scientists develop the shot and we start to administer it, those strains can change again. Once the flu shot is developed, you can’t recreate it, so the hope is that scientists are able to correctly predict any possible mutations for the next year in order to gain the most protection from the shot.

Some experts have said there may be a “mismatch” between the vaccine and the strains this year. What does that mean?
That gets back to mutation. We have the two strains of influenza A and the two strains of influenza B, and if one of those four strains starts to mutate, then the shot will no longer match the strains. So it might hit three of the four really well, but if the fourth starts to mutate, you’ll see a resurgence from that strain. That’s what the term “mismatch” means. It doesn’t happen every year. In fact, over time, the shot has been 40 to 60 percent effective, which translates into the prevention of literally millions of illnesses and flu-related doctor’s visits each year. For example, based on information from the CDC, during the 2017-2018 flu season, the vaccination prevented an estimated 6.2 million influenza illnesses, 3.2 million influenza-associated medical visits, 91,000 influenza-associated hospitalizations and 5,700 influenza-associated deaths.

How effective is this year’s vaccine?
We can’t know final numbers until flu season is over because the numbers include how many people got the shot, how many cases of the flu we saw, which strains of the flu they were, how many people were hospitalized — those types of things. Right now, it looks like it is on track with previous years, but it’s hard to say. The most recent data from the CDC shows most cases are influenza B this year, but this alone does not predict how effective the shot has been.

Right now, it’s February. Should you still get a flu shot if you haven’t gotten one?
Absolutely. The flu season usually goes from October all the way through April, sometimes even May. We see a bimodal uptick with a rise in cases in December and a rise in cases in February. Therefore, we recommend continuing to get the flu shot to not only avoid getting the flu, but to avoid complications from the flu, such as hospitalizations, influenza-associated illnesses like pneumonia or even death. So the short answer is, “Yes! Get your flu shot!”




Filters close

Showing results

110 of 2454
Released: 3-Jul-2020 10:25 AM EDT
Lack of lockdown increased COVID-19 deaths in Sweden
University of Virginia Health System

Sweden’s controversial decision not to lock down during COVID-19 produced more deaths and greater healthcare demand than seen in countries with earlier, more stringent interventions, a new analysis finds.

Released: 2-Jul-2020 3:10 PM EDT
Researchers outline adapted health communications principles for the COVID-19 pandemic
CUNY Graduate School of Public Health and Health Policy

The COVID-19 pandemic has introduced unique challenges for public health practitioners and health communicators that warrant an expansion of existing health communication principles to take into consideration.

Released: 2-Jul-2020 1:40 PM EDT
Collectivism drives efforts to reduce the spread of COVID-19
University of Kent

Research from the University of Kent has found that people who adopt a collectivist mindset are more likely to comply with social distancing and hygiene practices to help reduce the spread of COVID-19.

Released: 2-Jul-2020 12:30 PM EDT
Tiny mineral particles are better vehicles for promising gene therapy
University of Wisconsin-Madison

University of Wisconsin–Madison researchers have developed a safer and more efficient way to deliver a promising new method for treating cancer and liver disorders and for vaccination — including a COVID-19 vaccine from Moderna Therapeutics that has advanced to clinical trials with humans.

Newswise: Newer variant of COVID-19–causing virus dominates global infections
Released: 2-Jul-2020 12:10 PM EDT
Newer variant of COVID-19–causing virus dominates global infections
Los Alamos National Laboratory

Research out today in the journal Cell shows that a specific change in the SARS-CoV-2 coronavirus virus genome, previously associated with increased viral transmission and the spread of COVID-19, is more infectious in cell culture.

Newswise: From Wuhan to San Diego—How a mutation on the novel coronavirus has come to dominate the globe
Released: 2-Jul-2020 12:05 PM EDT
From Wuhan to San Diego—How a mutation on the novel coronavirus has come to dominate the globe
La Jolla Institute for Immunology

Two variants of the novel coronavirus (SARS-CoV-2), called G614 and D614, were circulating in mid-March. A new study shows that the G version of the virus has come to dominate cases around the world. They report that this mutation does not make the virus more deadly, but it does help the virus copy itself, resulting in a higher viral load, or "titer," in patients.

Released: 2-Jul-2020 11:50 AM EDT
New Study Explains Potential Causes for “Happy Hypoxia” Condition in COVID-19 Patients
Loyola Medicine

A new research study provides possible explanations for COVID-19 patients who present with extremely low, otherwise life-threatening levels of oxygen, but no signs of dyspnea (difficulty breathing). This new understanding of the condition, known as silent hypoxemia or “happy hypoxia,” could prevent unnecessary intubation and ventilation in patients during the current and expected second wave of coronavirus.

Released: 2-Jul-2020 10:15 AM EDT
Stemming the Spread of Misinformation on Social Media
Association for Psychological Science

New research reported in the journal Psychological Science finds that priming people to think about accuracy could make them more discerning in what they subsequently share on social media.

29-Jun-2020 9:00 AM EDT
Coronavirus damages the endocrine system
Endocrine Society

People with endocrine disorders may see their condition worsen as a result of COVID-19, according to a new review published in the Journal of the Endocrine Society.


Showing results

110 of 2454

close
0.87399